J&J to unload Indian consumer brands; Omega taps new U.K. agency; Bayer moves media-buying business;

> Johnson & Johnson ($JNJ) is selling the Indian rights to two consumer brands, Savlon antiseptic soap and Shower to Shower talcum powder, domestic media reports. Report

> Omega Pharma, currently in the process of selling itself, tapped a new agency to handle its U.K. and Ireland accounts; The Corner nabbed the business. Report

> Bayer moved a $11 million media account in Australia from Mediacom to PHD after a global review; worldwide, Mediacom kept four markets and PHD ended up with the other four, including Australia, Mumbrella says. Report

> ViiiV Healthcare expanded its campaign for HIV prevention and treatment in the U.S. South, funding grassroots outreach projects worth more than $2.8 million. Report

> Big Pharma companies are eyeing government contracts in Brazil, wooed by the market share guarantees offered under the new partnerships. Report

And Finally... Sanofi ($SNY) and Regeneron ($REGN) said they started a new study of their experimental drug dupilumab in atopic dermatitis. Release